Search Results - "Harkonen, W S"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Recombinant human relaxin in the treatment of scleroderma : A randomized, double-blind, placebo-controlled trial by SEIBOLD, J. R, KORN, J. H, COLLIER, D, WIGLEY, F. M, MERKEL, P. A, CSUKA, M. E, HSU, V, ROCCO, S, ERIKSON, M, HANNIGAN, J, HARKONEN, W. S, SANDERS, M. E, SIMMS, R, CLEMENTS, P. J, MORELAND, L. W, MAYES, M. D, FURST, D. E, ROTHFIELD, N, STEEN, V, WEISMAN, M

    Published in Annals of internal medicine (06-06-2000)
    “…Relaxin is a pregnancy-related hormone that has tissue remodeling and antifibrotic effects. Systemic sclerosis (scleroderma) is characterized by fibrosis of…”
    Get full text
    Journal Article
  2. 2

    Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy by Franz, Thomas J., Parsell, Dawn A., Halualani, Roger M., Hannigan, John F., Kalbach, Jacqueline P., Ma, ., Harkonen, W. Scott

    Published in International journal of dermatology (01-08-1999)
    “…Background: A new topical formulation of betamethasone valerate (BMV) with enhanced dermal penetration has been developed. Objective: These studies were…”
    Get full text
    Journal Article
  3. 3

    Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine by PIER, G. B, DESJARDIN, D, GROUT, M, GARNER, C, BENNETT, S. E, PEKOE, G, FULLER, S. A, THORNTON, M. O, HARKONEN, W. S, MILLER, H. C

    Published in Infection and Immunity (01-09-1994)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin by SPITLER, L. E, DEL RIO, M, KAWAHATA, R. T, STOUDEMIRE, J. B, FRADKIN, L. B, BAUTISTA, E. E, SCANNON, P. J, KHENTIGAN, A, WEDEL, N. I, BROPHY, N. A, MILLER, L. L, HARKONEN, W. S, ROSENDORF, L. L, LEE, H. M, MISCHAK, R. P

    Published in Cancer research (Chicago, Ill.) (15-03-1987)
    “…We conducted a trial of a murine monoclonal antimelanoma antibody-ricin A chain immunotoxin (XOMAZYME-MEL) in 22 patients with metastatic malignant melanoma…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen by WALKER, K. B, SERWONSKA, M. H, VALONE, F. H, HARKONEN, W. S, FRICK, O. L, SCRIVEN, K. H, RATNOFF, W. D, BROWNING, J. G, PAYAN, D. G, GOETZL, E. J

    Published in Journal of clinical immunology (01-03-1988)
    “…The concentrations of the neuropeptides substance P, somatostatin, and calcitonin gene-related peptide in human nasal secretions were quantified by…”
    Get full text
    Journal Article
  7. 7

    The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in rats by Stoudemire, J B, Mischak, R, Foxall, C, Harkonen, W S, Del Rio, M, Spitler, L E

    Published in Molecular biotherapy (01-09-1990)
    “…We conducted a study to determine if treatment with cyclophosphamide (CY) could suppress the formation of anti-murine and anti-ricin A chain antibodies in rats…”
    Get more information
    Journal Article
  8. 8

    Regulatory agency concerns in the manufacturing and testing of monoclonal antibodies for therapeutic use by Baker, D A, Harkonen, W S

    Published in Targeted diagnosis and therapy (1990)
    “…Monoclonal antibody-based therapeutic products are subject to the same regulatory review procedures and submissions requirements as more traditional…”
    Get more information
    Journal Article
  9. 9